Course 3: Toxicology and Mandatory Reporting

Course 3: Toxicology and Mandatory Reporting

Course Overview

This course provides guidance for social workers and mandated reporters on navigating notifications and reports to child welfare. It clarifies reporting duties, explains the process after a report is made, and explores recent legislation changes. The video also discusses the distinction between screening and toxicology testing, offers evidence-based recommendations for testing, and emphasizes the importance of safe feeding plans. It highlights the limitations of toxicology testing and the need for standardized approaches to ensure accurate interpretation and minimize negative consequences for patients and families.

Course Objectives

  1. Clarify their reporting duties as social workers and mandated reporters, understanding when a report to child welfare is warranted.

  2. Describe the process involved after a report is made to child welfare, including the potential investigations and interventions that may follow.

  3. Summarize recent legislation changes aimed at improving collaboration between healthcare workers and child welfare agencies.

  4. Differentiate between screening and toxicology testing in the context of perinatal substance use, understanding the appropriate use of each.

  5. Apply evidence-based recommendations to determine when toxicology testing is warranted in perinatal care settings.

  6. Discuss the importance of establishing safe feeding plans as part of perinatal substance use prevention, recovery,and treatment efforts.

  7. Identify the limitations and complexities associated with toxicology testing, including delayed results, false positives and negatives, and inconsistencies in interpretation.

  8. Understand the implications of toxicology testing on patients and families, emphasizing the need for standardized approaches and careful consideration of the potential impact.

Target Audience

Clinicians and Staff of Birthing Hospitals 

Course Contains Colorado Specific Information

Credit Information

Credit Type

* AMA PRA Category 1™

Number of Credits

1

* AMA PRA Category 1 ™ credits are used by physicians and other groups like PAs and certain nurses. Category 1 credits are accepted by the ARDMS, CCI, ACCME, and Sonography Canada.

Faculty

  • Christine Gold, MD is a Pediatric Hospitalist and an Associate Professor of Pediatrics for the University of Colorado School of Medicine. Her clinical work is in the level 1 newborn nursery setting. Dr. Gold is a co-chair for the Illuminate/SuPPoRT Colorado Policy Analysis Workgroup and a leader in substance-exposed newborn work at UCHealth. She works closely with organizations across Colorado to optimize and standardize care of substance-affected families.

  • Laurie Halmo, MD: Dr. Halmo is a medical toxicologist and an assistant professor of pediatrics in the Section of Hospital Medicine at the University of Colorado School of Medicine and Children’s Hospital Colorado. In addition to her clinical work as a pediatric hospitalist and medical toxicologist, Dr. Halmo is a volunteer faculty member at Rocky Mountain Poison and Drug Safety (the region’s Poison Control Center) and works closely with the region’s Pediatric Environmental Health Specialty Unit on a variety of initiatives related to children’s environmental health. She is also involved in numerous quality improvement initiatives related to the care of hospitalized toxicology patients, with a particular focus on children and maternal-infant dyads affected by substance use and children in out-of-home placement such as foster or kinship care.

  • Angela Swafford, MA, LCSW Angela Swafford (she/her) is a licensed clinical social worker and clinical informaticist with a passion for working with and advocating for individuals and families impacted by substance use disorders. She has worked at UCHealth since 2017 where she is a Program Director for the Behavioral Health Service Line. Angela is also a part of the MOMs+ team where she supports birthing hospitals in Colorado in providing equitable access to treatment and recovery for perinatal patients with substance use disorders. Angela has a diverse clinical background including experience working in human trafficking prevention, community mental health, managed care, and hospital settings. In 2018, Angela helped to develop and support the University of Colorado Hospital Emergency Department buprenorphine induction program which ignited her passion for helping individuals impacted by SUD. Angela has been involved in statewide initiatives such as the inpatient MAT task force led by the Colorado Hospital Association (CHA) and has testified before the Colorado Opioid and Other Substance Use Disorders Interim Study Committee at the Capitol. As an informaticist, Angela is an Epic Builder and holds two certifications from Epic in Verona, Wisconsin. Angela is also passionate about animal rescue and advocacy and fosters dogs saved from euthanasia in surrounding states with her husband and three resident dogs.

Disclosure

Christine Gold, Laurie Halmo and Angela Swafford disclose no such relationships exist

In compliance with the Essentials and Standards of the ACCME, the author of this CME tutorial is required to disclose any significant financial or other relationships they may have with commercial interests.

Estimated Time for Completion

1 hour

Date of Release

September 11th, 2024

Date of Most Recent Review

April 10th, 2025

Expiration Date

September 11th, 2027

Accreditation

Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Iowa Healthcare Collaborative (IHC) and Stader Opioid Consultants (SOC). The Iowa Healthcare Collaborative (IHC) is accredited by the IMS to provide continuing medical education for physicians. Designation: IHC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ Physicians should claim only the credit commensurate with the extent of their participation in the activity. Commercial Support: This activity was developed without support from any ineligible company. *The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company. Disclosure: IHC adheres to the Standards for Integrity and Independence in Accredited Continuing Education. The content of this activity is not related to products or the business lines of an ACCME-defined ineligible company. None of the planners or moderators for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing products used by or on patients. Note: We often receive questions about whether AMA PRA Category 1 Credits™ are accepted for nursing license renewal purposes. Please be informed that most state licensing boards across various disciplines nationwide recognize these credits as valid for continuing education. Many societies and credentialing bodies accept the AMA PRA Category 1 Credit™ as the top-tier continuing education credit and as an equivalent, provided the topic is relevant to the applicant’s field or discipline. After participating in our event, you will receive a Certificate of Attendance detailing the number of AMA PRA Category 1 Credits™ you can claim. This certificate does not automatically award continuing education credit, it is provided for self-reporting requirements and must be submitted to your respective state board for license renewal. We strongly recommend that each participant verify with their specific discipline’s licensing board to ensure acceptance of these credits. Thank you for your attention to this matter, and please feel free to reach out if you have further questions.

1 AMA PRA Category 1 Credit™